Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Clinical trial NCT02800486 · RECRUITING
Trial details
- NCT number
- NCT02800486
- Sponsor
- Northwell Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2035-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.